Patent · US Active

1,3,4-oxadiazole derivatives as DGAT1 inhibitors

US8003676B2 · kind B2 · utility

0Cited by
9References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 29, 2007
Grant dateAug 23, 2011
Priority date—
Expiry dateOct 17, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of formula (I), or salts thereof, which inhibit acetyl CoA (acetyl coenzyme A):diacylglycerol acyltransferase (DGAT1) activity are provided,wherein:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.